Offstream
news

---

Changes

1. Moderna announces that the U.S. FDA has fully approved their COVID-19 vaccine for all adults.
   2022-02-01 03:06:14 (First version)
2. The U.S. FDA issues a full approval for the Moderna COVID-19 vaccine for use in adults.
   (Current version)

---

Related

The Italian Medicines Agency recommends that anyone that received the Janssen COVID-19 vaccine should receive a booster dose of either the Pfizer or Moderna vaccines six months after they received their first dose due to a slow decline of efficacy against mild and moderate forms of the disease.
2021-11-3

The Food and Drug Administration authorizes booster doses of the Moderna and Janssen COVID-19 vaccines, as well as allow Americans to choose a different vaccine from their original inoculation as a booster.
2021-10-20

The U.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people.
2021-08-12

The Malaysian Ministry of Health grants a conditional approval for the Moderna COVID-19 vaccine for emergency use.
2021-08-5

Indonesia receives three million doses of the Moderna COVID-19 vaccine from the United States, facilitated through the COVAX initiative.
2021-07-11

Italy suspends the use of the Oxford-AstraZeneca vaccine in people under the age of 60 nationwide following the death of an 18-year-old girl yesterday and reports of other young people who have been hospitalized in critical condition after receiving their first dose of the vaccine. The Moderna and Pfizer vaccines will be used for the vaccination of people under the age of 60, including for people who already received a first dose of the AstraZeneca vaccine.
2021-06-11

Moderna says that it has requested full approval for its vaccine from the U.S. Food and Drug Administration. Currently, it has only been approved for emergency use.
2021-06-1

Moderna says that their vaccine is 100% effective in teenagers between the ages of 12 and 17. They say that they will seek approval from the U.S. Food and Drug Administration in early June.
2021-05-25

The Centers for Disease Control's Advisory Committee on Immunization Practices recommends Johnson & Johnson's single-shot vaccine for people over the age of 18, a day after the Food and Drug Administration approved the emergency use of the vaccine.
2021-02-28

The Food and Drug Administration approves the single-dose Johnson & Johnson vaccine for emergency use in the United States.
2021-02-27